Last reviewed · How we verify
Prothiazin (isopromethazine)
Prothiazin (generic name: isopromethazine) is a isopromethazine drug. It is currently in unknown development.
Isopromethazine works by blocking histamine receptors in the brain, which helps to reduce symptoms of nausea, vomiting, and dizziness.
Prothiazin, also known as isopromethazine, is a small molecule drug in the isopromethazine class. Its exact target is unknown, but it is used to treat various conditions. Unfortunately, there is limited information available on its commercial status, approved indications, and pharmacokinetic properties. Further research is needed to fully understand its mechanism of action and safety profile. As a result, it is not possible to provide a comprehensive summary of this medication.
At a glance
| Generic name | isopromethazine |
|---|---|
| Drug class | isopromethazine |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Imagine your brain has special locks that histamine can open to make you feel sick. Isopromethazine is like a key that blocks those locks, so histamine can't make you feel sick. This helps to reduce symptoms like nausea and vomiting.
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS) (PHASE3)
- A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003) (PHASE1,PHASE2)
- Standardized Sleep Bundle for Cardiac Surgery Patients (NA)
- Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007) (PHASE3)
- Trial of Diphenhydramine for Sleep in Children With Autism (PHASE2)
- Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants (PHASE1)
- Trial of Zolpidem for Sleep in Children With Autism (PHASE2)
- The Effect of Losartan on Cephalexin (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Prothiazin CI brief — competitive landscape report
- Prothiazin updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Prothiazin
What is Prothiazin?
How does Prothiazin work?
What is the generic name of Prothiazin?
What drug class is Prothiazin in?
What development phase is Prothiazin in?
Related
- Drug class: All isopromethazine drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing